ReviewFrontiers in immunology2025

The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?

Fadila Kouhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.